Shueng, P.-W.; Chan, H.-W.; Lin, W.-C.; Kuo, D.-Y.; Chuang, H.-Y.
Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism. Int. J. Mol. Sci. 2022, 23, 6501.
https://doi.org/10.3390/ijms23126501
AMA Style
Shueng P-W, Chan H-W, Lin W-C, Kuo D-Y, Chuang H-Y.
Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism. International Journal of Molecular Sciences. 2022; 23(12):6501.
https://doi.org/10.3390/ijms23126501
Chicago/Turabian Style
Shueng, Pei-Wei, Hui-Wen Chan, Wei-Chan Lin, Deng-Yu Kuo, and Hui-Yen Chuang.
2022. "Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism" International Journal of Molecular Sciences 23, no. 12: 6501.
https://doi.org/10.3390/ijms23126501
APA Style
Shueng, P.-W., Chan, H.-W., Lin, W.-C., Kuo, D.-Y., & Chuang, H.-Y.
(2022). Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism. International Journal of Molecular Sciences, 23(12), 6501.
https://doi.org/10.3390/ijms23126501